|
" SYK of Chronic GVHD: A Novel Therapeutic Approach Targeting Aberrant B Cell Signaling with Fostamatinib” |
08/17/2022 - 8:00am to 9:00am EDT |
|
"Identification of an optimal mutant allele frequency in cell-free DNA to predict sensitivity for actionable driver mutations in colorectal and pancreatic adenocarcinoma", “LRP1b as an indicator for sensitivity to immunotherapy” |
08/03/2022 - 8:00am to 9:00am EDT |
|
"What's CUP, Doc? A Review of Cancer of Unknown Primary” |
08/31/2022 - 8:30am to 9:00am EDT |
|
A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia |
10/26/2022 - 8:00am to 9:00am EDT |
|
An overview of the NCI’s Division of Cancer Prevention |
09/28/2022 - 8:00am to 9:00am EDT |
|
Annual Program Overview |
06/22/2022 - 8:00am to 9:00am EDT |
|
Believing in Science but Trusting Your Gut/Pittsburgh, People, and Prostates |
07/13/2022 - 8:00am to 9:00am EDT |
|
Body composition in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitors |
08/17/2022 - 8:30am to 9:00am EDT |
|
Cigarettes and Chemo: The Importance of Smoking Cessation After a Cancer Diagnosis & Preventative cancer vaccines |
09/07/2022 - 8:00am to 9:00am EDT |
|
Complement Activation in HIT |
11/09/2022 - 8:00am to 9:00am EST |
Facebook
Twitter
LinkedIn
Forward